PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
3.02 - 3.02
2.85 - 3.74
400 / 3.8K (Avg.)
12.58 | 0.24
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.43%
Revenue growth above 1.5x IXX.DE's 0.17%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
8.32%
Gross profit growth above 1.5x IXX.DE's 3.28%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
229.06%
EBIT growth above 1.5x IXX.DE's 109.01%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
229.06%
Positive operating income growth while IXX.DE is negative. John Neff might view this as a competitive edge in operations.
133.80%
Net income growth 1.25-1.5x IXX.DE's 108.66%. Bruce Berkowitz would see if strategic cost cutting or product mix explains this difference.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
26.96%
10Y revenue/share CAGR under 50% of IXX.DE's 64.21%. Michael Burry would suspect a lasting competitive disadvantage.
26.96%
5Y revenue/share CAGR at 75-90% of IXX.DE's 32.68%. Bill Ackman would encourage strategies to match competitor’s pace.
26.96%
3Y revenue/share CAGR above 1.5x IXX.DE's 4.59%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
63.31%
Positive 10Y CAGR while IXX.DE is negative. John Neff might see a substantial advantage in bottom-line trajectory.
63.31%
Positive 5Y CAGR while IXX.DE is negative. John Neff might view this as a strong mid-term relative advantage.
63.31%
Positive short-term CAGR while IXX.DE is negative. John Neff would see a clear advantage in near-term profit trajectory.
18.10%
Equity/share CAGR of 18.10% while IXX.DE is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
18.10%
Below 50% of IXX.DE's 60.50%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
18.10%
3Y equity/share CAGR at 75-90% of IXX.DE's 21.41%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
21.59%
AR growth of 21.59% while IXX.DE is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
3.91%
Inventory growth well above IXX.DE's 4.98%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
0.82%
Asset growth above 1.5x IXX.DE's 0.05%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
-16.86%
We’re deleveraging while IXX.DE stands at 79.08%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-2.97%
We cut SG&A while IXX.DE invests at 8.48%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.